Relay Therapeutics, Inc. (RLAY) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: RLAY) | Delayed: 18.03 +0.59 (3.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.44 | 52 Week High | $ | |||
| Open | $17.57 | 52 Week Low | $ | |||
| Day High | $18.28 | P/E | N/A | |||
| Day Low | $17.08 | EPS | $ | |||
| Volume | 3,729,957 | |||||
